Search Within

Gilles Andre Salles

Formats
  1. Meeting Abstract (182)
  2. Journal Article (79)
  3. Research Letter (18)
  4. Review (18)
  5. Editorial (5)
  6. Correspondence (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Section (1)
Groups
  1. Department of Medicine (310)
  2. Hematologic Malignancies, Division of (310)
  3. Center for Hematologic Malignancies (168)
  4. Lymphoma (164)
  5. Hematology-Oncology Fellows (141)
  6. Survivorship Research (118)

More Groups

People
  1. Maria Palomba (112)
  2. Andrew Zelenetz (76)
  3. Anita Kumar (66)
  4. Lorenzo Falchi (66)
  5. Gunjan Shah (63)
  6. Miguel-Angel Perales (60)

More People

Years
  1. 2025 (26)
  2. 2024 (68)
  3. 2023 (97)
  4. 2022 (69)
  5. 2021 (44)
  6. 2020 (6)
Publications
  1. Blood (127)
  2. Hematological Oncology (28)
  3. Journal of Clinical Oncology (18)
  4. Blood Advances (16)
  5. Haematologica (15)
  6. British Journal of Haematology (10)

More Publications

Publishers
  1. American Society of Hematology (144)
  2. Wiley Blackwell (30)
  3. Elsevier Inc. (21)
  4. American Society of Clinical Oncology (18)
  5. Ferrata Storti Foundation (15)
  6. Nature Publishing Group (14)

More Publishers

Results (310)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor DNA (CTDNA) status and clinical outcomes in patients (PTS) with previously untreated diffuse large B‐cell lymphoma (DLBCL) in the POLARIX study
    Meeting Abstract

    Herrera, A. F.; Tracy, S.; Sehn, L. H.; Jardin, F.; Lenz, G.; Trněný, M.; Salles, G.; Flowers, C. R.; Tilly, H.; Sharman, J. P.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Chromatin accessibility profiling to increase diagnostic accuracy and refine cell‐of‐origin classification of mature T‐cell lymphomas
    Meeting Abstract

    Julia, E.; Mareschal, S.; Chebel, A.; Camille, G.; Missaglia, E.; Rattina, V.; Lours, C.; Testard, Q.; Tschantz, M.; Sebai, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • RE-MIND2: Comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Peters, A.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Annals of Hematology (2023)

    Fulltext@MSK | Save
  • CAR T-cell therapy in large B cell lymphoma
    Conference Paper

    Boardman, A. P.; Salles, G.
    Wiley Blackwell (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Genetic and microenvironment features do not distinguish follicular lymphoma patients requiring immediate or deferred treatment
    Research Letter

    Stevens, W. B. C.; Los-de Vries, G. T.; Langois-Jacques, C.; Clear, A. J.; Stathi, P.; Sander, B.; Rosenwald, A.; Calaminici, M.; Hoster, E.; Hiddemann, W.; more...
    HemaSphere (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Molecularly targeted epigenetic therapy with mocetinostat in relapsed and refractory non-Hodgkin lymphoma with CREBBP or EP300 mutations: An open label phase II study
    Research Letter

    Qualls, D.; Noy, A.; Straus, D.; Matasar, M.; Moskowitz, C.; Seshan, V.; Dogan, A.; Salles, G.; Younes, A.; Zelenetz, A. D.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save